Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Mariëlle Eerdekens, MD
JCP
Original Research
Efficacy and Tolerability of Oral Paliperidone Extended-Release Tablets in the Treatment of Acute Schizophrenia: Pooled Data From Three 6-Week, Placebo-Controlled Studies
May 11, 2008
Herbert Y. Meltzer
,
William V. Bobo
,
Isaac F. Nuamah
, et al
JCP
Original Research
Safety and Efficacy of Long-Acting Risperidone in Schizophrenia: A 12-Week, Multicenter, Open-Label Study in Stable Patients Switched From Typical and Atypical Oral Antipsychotics
August 16, 2004
Jean-Pierre Lindenmayer
,
Els Eerdekens
,
Sally A. Berry
, et al
JCP
Original Research
Health-Related Quality of Life in Patients With Schizophrenia During Treatment With Long-Acting, Injectable Risperidone
April 1, 2004
Henry A. Nasrallah
,
Inge Duchesne
,
Angelika Mehnert
, et al
JCP
Original Research
Treatment of Schizophrenia With Long-Acting Injectable Risperidone: A 12-Month Open-Label Trial of the First Long-Acting Second-Generation Antipsychotic
October 15, 2003
W. Wolfgang Fleischhacker
,
Mariëlle Eerdekens
,
Keith Karcher
, et al
